Summary. Muscarinic cholinergic receptors and choline acetyltransferase (CHAT) activity were studied in postmortem brain tissue from patients with Huntington's disease and matched control subjects. In comparison with controls, reductions in ChAT activity were found in the hippocampus, but not in the temporal cortex in Huntington's disease. Patients with Huntington's disease showed reduced densities of the total number of muscarinic receptors and of M-2 receptors in the hippocampus while the density of M-1 receptors was unaltered. Muscarinic receptor binding was unchanged in the temporal cortex. These results indicate a degeneration in Huntington's disease of the septo-hippocampal cholinergic pathway, but no impairment of the innominato-cortical cholinergic system.
Introduction
Huntington's disease is characterized clinically by choreiform movements and progressive dementia. Dementia in Alzheimer's disease and Parkinson's disease appears to be associated with degeneration of subcortico-cortical cholinergic systems [5, 7, 9] . While acetylcholine-containing neurons are damaged in the basal ganglia in Huntington's disease [2, 10] , the status of the cholinergic afferent projections to the neocortex and hippocampus is less clear. We have examined choline acetyltransferase (CHAT) activity and muscarinic cholinergic receptor binding in the temporal cortex (Brodmann area 38) and hippocampus in Huntington's disease.
Patients and methods
Brain tissue was obtained at autopsy from 12 patients with neuropathologically confirmed Huntington's disease and from 12 matched 
Results
In comparison with controls, reductions in ChAT activity were found in the hippocampus but not in the tem- Muscarinic receptor binding was unaltered in the temporal cortex. Alterations in the equilibrium dissociation constants (KD) were not observed.
Discussion
The reduction in ChAT activity and in muscarinic M-2 receptors, which are thought to be located mainly presynaptically, indicates a degeneration of the cholinergic pathway from the septum to the hippocampus. This is supported by decreased ChAT activity in septal nuclei [10] . The present results of unaltered cortical ChAT activity and putatively pre-synaptic M-2 receptors suggest that the ascending cholinergic system from the substantia innominata to the neocortex is not damaged in Huntington's disease. This is consistent with previous reports showing a preservation of neurons in the nucleus basalis of Meynert [3, 6] . Dementia is associated with neuronal damage or loss in the nucleus basalis in Alzheimer's disease and Parkinson's disease [8] . The findings in Huntington's disease, however, indicate that damage to this region is not a prerequisite for the development of dementia. The cognitive impairment in Huntington's disease may be related to hippocampal deficits and damage to neuronal systems within the basal ganglia, although it cannot be ruled out that the dementia might stem directly from cortical atrophy [4] .
